Prescribing Update Newsletter – January 2021

Prescribing support newsletters aim to inform readers of work done by the unit and work in progress, to help tailor local work plans and highlight any ‘topical’ issues in prescribing or medicines management.

If you have any suggestions for future topics for the newsletter, then please contact nuth.nyrdtc.rxsupp@nhs.net

Monthly Horizon Scanning Report – Jan 2021

Monthly horizon scanning reports are designed to inform the NHS about new products, significant changes to product licenses, significant new guidance, and decisions that have been made by recognised bodies. 

This information is produced for use by NHS healthcare professionals. 

Impact of Priadel Price Change on CCG Prescribing Budgets

This bulletin aims to raise awareness of the NHS price increase for Priadel® (lithium carbonate) tablets as of November 2020 and the resulting cost impact to primary care. While discussions between the DHSC and the manufacturer of Priadel have prevented its discontinuation from the UK market at this stage, the renegotiated price in November 2020 has seen the cost more than double from December 2020.

There are three versions of this publication; please select the appropriate version for your region below.

Cardiovascular outcomes associated with SGLT2 inhibitors (update 2)

Overview

Medicines in Practice is a series of evidence–based publications specifically designed to support stakeholder medicines optimisation services. The series aims to maximise health gains through the optimum use of medicines, by influencing and changing prescribing behaviour.

The sodium-glucose co-transporter 2 (SGLT2) inhibitors canagliflozin, dapagliflozin, empagliflozin and ertugliflozin are licensed for the improvement of glycaemic control in adults with type 2 diabetes, a population at increased risk of cardiovascular events. Recent clinical trials and cohort studies have assessed whether the SGLT2 inhibitors reduce this risk.

Download the full review below to read more.

Antibiotic use in children: liquid vs. solid oral dosage forms

This bulletin addresses cost-effective prescribing of oral antimicrobials in children without dysphagia. Liquid antimicrobial preparations are significantly more expensive than solid oral dosage forms, so the bulletin aims to
present the current prescribing patterns of antimicrobial formulations in the paediatric population on a CCG Level.

This review is older than 18 months; in view of the continued emergence of new evidence, readers are recommended to re-check the biomedical literature.

There are three versions of this publication; please select the appropriate version for your region below.

Prescribing Update Newsletter – Jan 2020

Prescribing support newsletters aim to inform readers of work done by the unit and work in progress, to help tailor local work plans and highlight any ‘topical’ issues in prescribing or medicines management.

If you have any suggestions for future topics for the newsletter, then please contact nuth.nyrdtc.rxsupp@nhs.net